Matea Ugulin
Gregory Bombard
Gregory S. Bombard is a trial lawyer whose practice focuses on trade secret litigation. Greg also handles other IP litigation and complex commercial disputes. His trade secret clients are primarily in high tech industries, including biotech, medical devices, software, robotics, fintech, and manufacturing. Greg is an author of the ABA’s Guide to Protecting and Litigating Trade Secrets, 2nd Ed., and co-chairs of the ABA’s Trade Secret Litigation Subcommittee. Greg is a shareholder in the Boston office of the international law firm Greenberg Traurig, LLP. He can be reached at [email protected].
Kelly Knaapen Arts
Kelly is Senior Director, European Patents and IP Operations at Merus. She has a Master’s degree in Biomedical Sciences and started her career as European patent attorney in private practice. In 2019 she joined Merus, where she is responsible for the operation of the IP department, directs the IP strategy, and advances Merus’ patent portfolio relating to multispecific antibodies. Working together with several outside counsel and collaboration partners, her focus is on establishing a strong IP position and freedom to operate for Merus’ key platform technology and clinical and pre-clinical products to support Merus’ mission to close in on cancer.
Martina Hufnal
Sebastian Vedel
Sebastian Vedel is Nordic lead at Napier, a UK based company providing AML solutions powered by AI. Sebastian has experience in complex, large scale financial crime implementations and has been leading the expansion of Napier in the Nordics since the beginning of 2022. Prior to joining Napier, Sebastian spent almost 3 years with Danske Bank and was among others part of a Financial Crime Execution Oversight team driving Anti Financial Crime IT initiatives. He has previously worked at EY, where he was part of the Financial Services Performance Improvement team looking at performance initiatives across core banking functions enabled by IT.
Will Monk
Will has more than twenty-five years of experience leading global financial crime teams, transformation programmes, and product strategy and development across a wide range of financial services organisations. He led the financial crime quality team at NatWest, worked as a regtech consultant advising global businesses including Santander, J P Morgan and Standard Chartered, and was Group Head of KYC Operations at HSBC. Will brings his deep understanding of the challenges faced by compliance teams to his role as chief product officer at Napier, where he oversees the development of a new generation of products designed to optimise resources and make a quantifiable difference to results.
Renato Lemgruber
Bachelor's Degree in Biological Sciences (Federal University of Parana, Brazil, 2009).
Master of Science in Genetics, Conservation and Evolutionary Biology (National Institute of Amazonian Research, Brazil, 2012).
PhD in Biotechnology (Systems and Synthetic Biology) (Australian Institute for Bioengineering and Nanotechnology, University of Queensland, Australia, 2019).
Member of The Higher Education Academy (HEA) as an Associate Fellow (Since March 2019)
Kyoungsub Song Ph.D.
Kyoungsub Song has more than 15 years experience in the field of liver disease including NASH, cirrhosis, and cancers. He worked as a postdoc and instructor at Tulane University, School of Medicine. He joined LISCure Bioscience in 2020 and now serves as CTO. He led the research and development drugs for NASH in the clinical stage by conducting research on the mechanism and efficacy of candidate substances and preclinical experiments at LISCure. He was actively involved in LISCure’s global partnerships with Mayo Clinic and Scripps research.